Bios Life has raised $25 million in seed funding to develop digital twins for cancer screening, led by Redmile, Vsquared Ventures, and Kindred Capital.
Amount Raised
$25 Million
Round Type
Seed
BostonBiotechnologyHealth CareMedicalInvestors
Description
Bios Life has emerged from stealth mode with $25 million in seed funding, aimed at developing digital twin cancer risk models. The funding round is led by Redmile, Vsquared Ventures, and Kindred Capital, marking the company's first outside funding. A multi-year partnership with Tempus complements its innovative approach to cancer screening. The company's technology seeks to address the significant gaps in access to tailored care for high-risk individuals and cancer survivors.
Quick answer
Bios Life raised $25 Million in a Seed round, dated August 11, 2026. Investors: Redmile, Vsquared Ventures and Kindred Capital. Bios Life is based in Boston, Massachusetts, United States.
- How much did Bios Life raise?
- Bios Life raised $25 Million in a Seed round on August 11, 2026.
- Who invested in Bios Life?
- Redmile, Vsquared Ventures and Kindred Capital are named as investors in this round.
- What does Bios Life do?
- Bios Life is a healthtech company focused on developing digital twin cancer risk models.
- Where is Bios Life based and how big is it?
- Bios Life is based in Boston, Massachusetts, United States. Fundz records about 1,000 employees.
- Who are the decision-makers at Bios Life?
- Fundz holds 2 contacts at Bios Life, including the Chief Culture Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Biotechnology around the same time
Companies in the same sectors as Bios Life that raised within 45 days of this round, from Fundz verified event records.
- Redefine Surgery raised $10M (Pre-Seed) on September 24, 2026.
- SenseTime MedTech raised $100M (Series B) on September 24, 2026.
- Cascader raised an undisclosed amount (Seed) on September 23, 2026.
- Betterhood raised $1.2M (Seed) on September 23, 2026.
- Anaconda BioMed raised $56M on September 23, 2026.
- UltraSight raised $24M (Series B) on September 23, 2026.
Who to call at Bios Life, and when
A new round usually means Bios Life is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Bios Life raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Bios Life, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Bios Life. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Bios Life raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Bios Life raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.